Appendix

1. Quality 4.0 technologies to enhance traditional Chinese medicine for overcoming healthcare challenges during COVID-19

1. Analysis of the hotspots and trends in traditional Chinese medicine immunomodulation research based on bibliometrics
2. Research on classification diagnosis model of psoriasis based on deep residual network
3. Novel pyrimidine-benzimidazole hybrids with antibacterial and antifungal properties and potential inhibition of SARS-CoV-2 main protease and spike glycoprotein
4. Evaluation of Baishao(Paeoniae Radix Alba)and Chishao(Paeoniae Radix Rubra)from different origins based on characteristic spectra of amino acids
5. Network pharmacology research and experimental verification of Huangqi(Astragalus Radix)and Jinyingzi(Rosae Laevigatae Fructus)in treating benign prostatic hyperplasia
6. Comparison of mechanisms and efficacies of five formulas for improving blood circulation and removing blood stasis
7. Instructions for Authors